Advent to acquire controlling stake in RA Chem Pharma at $133m valuation

Advent to acquire controlling stake in RA Chem Pharma at $133m valuation

Photo: Reuters

Adding to a spate of private equity investments in the Indian pharma sector this year, PE firm Advent International on Thursday said that it has signed a definitive agreement to acquire a controlling stake in RA Chem Pharma Ltd, a vertically integrated pharmaceutical company promoted by Micro Labs Ltd, the PE investor said in a statement.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter